post tracheal intubation sorethroat. Anaesthesiology devices associated with adverse incidents
Conditions
Interventions
Intervention 1: Intervention1: intracuff Desxamethasone, 16 mg, during intraoperation intubation period. Intervention 2: Intervention2: intracuff Magnesium sulfate, 50 mg/kg , during intraoperation in
Prevention
Intervention1: intracuff Desxamethasone, 16 mg, during intraoperation intubation period.
Intervention2: intracuff Magnesium sulfate, 50 mg/kg , during intraoperation intubation period.
control: intracuff air, during intraoperation intubation period.
Sponsors
Islamic Azad University, Tehran Medical Branch, Vice chansellor for research
Eligibility
Sex/Gender
All
Age
16 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age>16 yr; ASA class 1 or 2; no URI infection or sorethroat at the time of surgery; no possibility of difficult air way; no candidate of surgery on air way; candidate of general anesthesia & tracheal intubation; no contraindication for receiving steroids or Magnesium sulfate . Exclusion criteria: intraopertion pharyngeal packing; intraopertion NG tube placement.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sorethroat. Timepoint: After recovery, at the end of operation day, on the morning of the first post operation day. Method of measurement: questionare (VAS method). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLadan Ansari
Islamic Azad University, Tehran Medical Branch, Booali Hospital
Outcome results
None listed